SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000950115-00-000685
Filing Date
2000-05-12
Accepted
2000-05-12 00:00:00
Documents
6

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A SC 13D/A 44581
2 JOINT FILING AGREEMENT EX-8 1786
3 STOCK PURCHASE AGREEMENT EX-9 153001
4 REGISTRATION RIGHTS AGREEMENT EX-11 75022
5 AMENDMENT NO. 1 TO STOCKHOLDERS' AGREEMENT EX-12 10077
6 AMENDMENT TO RESTATED REGISTRATION RIGHTS AGREE. EX-13 7842
  Complete submission text file 0000950115-00-000685.txt   295053
Mailing Address CASTOR & KENSINGTON AVENUES PHILADELPHIA PA 19124-5694
Business Address CASTOR & KENSINGTON AVES PHILADELPHIA PA 19124-5694 2152892220
IMPAX LABORATORIES INC (Filed by) CIK: 0001003642 (see all company filings)

IRS No.: 650403311 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address CASTOR & KENSINGTON AVENUES PHILADELPHIA PA 19124-5694
Business Address CASTOR & KENSINGTON AVES PHILADELPHIA PA 19124-5694 2152892220
IMPAX LABORATORIES INC (Subject) CIK: 0001003642 (see all company filings)

IRS No.: 650403311 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-48867 | Film No.: 628553
SIC: 2834 Pharmaceutical Preparations